Shimon Furusato

Mr. Shimon Furusato

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
KKKentaro Kurogochi
Kentaro Kurogochi
SFShimon Furusato
Shimon Furusato
ETEmi Takahashi
Emi Takahashi
MTMiho Tabata
Miho Tabata
MMMasashi Mizuno
Masashi Mizuno
MUMasami Uechi
Masami Uechi
Background: Myxomatous mitral valve disease (MMVD) in dogs commonly progresses to congestive heart failure, which carries a poor prognosis. Mitral valve repair (MVR) is a recognized treatment for advanced-stage MMVD. Hypothesis/Objectives: Identify the risk factors and prognosis in dogs undergoing MVR. Animals: We enrolled 1019 dogs with MMVD (ACVIM stages B2, C, and D) that underwent MVR between January 2017 and December 2020. Methods: Medical records from a single institution were retrospectively reviewed. Early and late postoperative periods were defined as < 100 days and 100–1400 days after surgery, respectively. The outcome was time to a composite of all-cause mortality, onset of postoperative congestive heart failure, or undergoing a second MVR (surgical revision). Results: In the early postoperative period, 61 dogs experienced the composite outcome; in the late period, 211 dogs did. No dogs underwent a second MVR. The incidence rate was 19.6 and 7.1 events per 1000 dog-months in the early and late periods, respectively. Compared with stage B2 dogs, stage D dogs had 2.2 times the daily hazard of experiencing an early postoperative event. In the late period, increasing age (per year; hazard ratio [HR], 1.3), higher body weight (per kilogram; HR, 1.1), Cavalier King Charles Spaniels compared with Chihuahuas (HR, 2.2), and preoperative tricuspid valve regurgitant velocity > 3.7 m/s (HR, 2.5) were associated with the events. Conclusions and Clinical Importance: A higher incidence of the event was observed in the early postoperative period rather than later, with the outcome varying according to MMVD condition and patient-specific factors.

1 July 2025 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
SFShimon Furusato
Shimon Furusato
KKKentaro Kurogochi
Kentaro Kurogochi
MMMasashi Mizuno
Masashi Mizuno
SSSatoru Shinoda
Satoru Shinoda
RTReo Tanoshima
Reo Tanoshima
MUMasami Uechi
Masami Uechi
Background: Mitral valve repair (MVR) has emerged as a novel surgical intervention for dogs with myxomatous mitral valve disease (MMVD). However, no objective risk assessment method has been established for these cases. Objectives: The primary aim of this study was to develop and evaluate preoperative prediction models for 30-day postoperative mortality in dogs undergoing MVR. The secondary aim was to assess the association between short-term predictive risk and long-term mortality following MVR. Animals: A total of 2089 client-owned dogs with MMVD that underwent MVR between 2016 and 2023 were included. Methods: This was a single-center retrospective cohort study. Preoperative variables including demographic data, routine blood test results, diagnostic imaging examination data, and medication history were selected as predictor candidates. Prediction models for 30-day all-cause mortality were developed using these variables and shrinkage estimation methods, and the model performances were evaluated. The association between the predicted probabilities and 2-year cumulative all-cause mortality was assessed using Cox proportional hazards analysis. Results: The 30-day all-cause mortality rate after MVR was 4.9% (102/2089). The best preoperative prediction model for 30-day all-cause death demonstrated low-to-moderate discrimination abilities (c-statistics, 0.654) and good calibration performance (slope = 1.003; intercept = 0.007; Eavg = 0.002) in internal validation. The quartile grouping of the predicted 30-day all-cause mortality risk was associated with 2-year mortality. Conclusions and Clinical Importance: The preoperative prediction model for short-term mortality in dogs undergoing MVR demonstrated acceptable predictive performance. The prediction model may provide an objective preoperative risk assessment in dogs undergoing MVR at this center.

8 February 2024 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
YNYasuyuki Nii
Yasuyuki Nii
ETEmi Takahashi
Emi Takahashi
MTMiho Tabata
Miho Tabata
SFShimon Furusato
Shimon Furusato
MKMasaya Katsumata
Masaya Katsumata
MUMasami Uechi
Masami Uechi
Hypoglycemia has not been previously reported as a postoperative complication of mitral valve repair (MVR) in dogs; however, the authors have encountered cases of hypoglycemia after MVR. This study aimed to determine the incidence of hypoglycemia in dogs after MVR and investigate its causes. Blood glucose levels were measured at multiple timepoints in dogs undergoing MVR. Simultaneously, insulin and glucagon blood concentrations in dogs with hypoglycemia preoperatively and postoperatively were compared to verify the physiological responses to hypoglycemia. Furthermore, risk factors for hypoglycemia, using variables selected based on the characteristics of MVR and dogs undergoing MVR, were examined prospectively. The incidence of hypoglycemia after MVR was 14.2%, and plasma glucagon concentrations increased in these dogs (mean: 260 pg/mL and 644 pg/mL pre- and postoperatively, p < 0.001), whereas serum insulin concentrations decreased (median: 0.50 ng/mL and 0.29 ng/mL pre- and postoperatively, p = 0.002). Therefore, hyperinsulinemia or hypoglucagonemia is unlikely to be the cause of postoperative hypoglycemia. The identified risk factors for hypoglycemia included low body weight and asymptomatic myxomatous mitral valve disease. Monitoring blood glucose levels after MVR should be included in the standard hospitalization plan to prevent hypoglycemic emergencies in dogs.

11 October 2025 in Journal of Veterinary Cardiology
Verified
Journal Article
Open access
SFShimon Furusato
Shimon Furusato
HAH. Arai
H. Arai
SSSatoru Shinoda
Satoru Shinoda
KHK. Harada
K. Harada
MMM. Mizuno
M. Mizuno
MUMasami Uechi
Masami Uechi
N-terminal pro-atrial natriuretic peptide (NT-proANP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) are established biomarkers in veterinary cardiology, but their postoperative dynamics in dogs remain unclear. The aims of this study were to describe longitudinal profiles of these biomarkers and to explore associated factors in dogs undergoing mitral valve repair (MVR). This single-center, prospective observational cohort study enrolled 109 dogs with myxomatous mitral valve disease that underwent MVR. N-terminal pro-atrial natriuretic peptide, NT-proBNP, renal parameters, echocardiography, and radiography were assessed repeatedly up to six months postoperatively. Serial data were analyzed using multivariable linear mixed-effects regression. Cardiac reverse-remodeling occurred shortly after MVR, whereas the natriuretic peptides (NPs) declined gradually with high variability. In multivariable analysis, log2-NT-proANP was associated with older age (0.12 [95% confidence interval, 0.05 to 0.20] standard deviation [SD]), lower body weight (-0.11 [-0.18 to -0.03] SD), and higher serum creatinine (0.18 [0.12 to 0.23] SD). Log2-N-terminal pro-B-type natriuretic peptide was associated with older age (0.11 [0.03 to 0.20] SD), lower body weight (-0.09 [-0.18 to -0.00] SD), higher serum creatinine (0.07 [0.01 to 0.14] SD), and right ventricular pressure overload (0.35 [0.12 to 0.57] SD). While single-point NP measurements did not reflect postoperative cardiac size, relative NT-proBNP changes were associated with subsequent cardiac size alterations. Single-center design limits generalizability. Interobserver variability in imaging could introduce measurement error. Natriuretic peptide reductions following MVR were gradual and variable. Age, body weight, renal function, and right ventricular pressure overload may influence NP concentrations. Interpreting single postoperative NP measurements may be challenging.

17 October 2026 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
SKShingo Kurihara
Shingo Kurihara
SFShimon Furusato
Shimon Furusato
KHKazuhisa Hatayama
Kazuhisa Hatayama
KFKiyohide Fushimi
Kiyohide Fushimi
SSSayuri Shimizu
Sayuri Shimizu

1 July 2026 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
SFShimon Furusato
Shimon Furusato
KSKeita Sato
Keita Sato
YNYasuyuki Nii
Yasuyuki Nii
RTReo Tanoshima
Reo Tanoshima
MUMasami Uechi
Masami Uechi
Background: While serum total bilirubin concentration (Tbil) has emerged as a potential prognostic marker in dogs with myxomatous mitral valve disease (MMVD) after mitral valve repair (MVR), its dose–response relationship and underlying pathophysiological mechanisms remain unclear. Hypothesis/Objectives: To characterize the dose–response relationships between preoperative Tbil and 2-year all-cause mortality after MVR and explore the role of right-sided cardiac compromise. Animals: Two thousand sixty-three (cohort A) and 301 (cohort B) dogs with MMVD undergoing MVR at a single center. Methods: This retrospective cohort study used multivariable Cox regression to assess the association between Tbil and 2-year mortality in cohort A. Cohort B evaluated relationships among Tbil, hepatic congestion, and right-sided overload. Results: In cohort A, preoperative Tbil showed a linear positive association with 2-year all-cause mortality even within reference interval (ie, adjusted hazard ratio [0.3 vs. 0.1 mg/dL]: 1.33; 95% CI, 1.04-1.70). This association disappeared in dogs surviving beyond 30 days. Furthermore, higher preoperative Tbil levels were associated with an increased incidence of cardiac-related 30-day deaths in cohort A, and with right-sided cardiac overload at discharge in cohort B, which resolved by one month postoperatively. Hepatic congestion was associated with right-sided overload but not Tbil levels. Conclusions and clinical importance: Subtle preoperative Tbil elevations were associated with short-term all-cause mortality and transient right-sided overload, warranting careful interpretation even within reference intervals. However, the pathophysiological mechanism linking Tbil to postoperative prognosis remains to be elucidated. Abstract Translated to Japanese: 背景 血清総ビリルビン濃度 (Tbil) は、僧帽弁修復術 (MVR) 後の粘液腫様僧帽弁疾患 (MMVD) の犬における予後因子の可能性が指摘されているが、その用量反応関係および病態生理学的機序は依然として不明である。 目的 術前 Tbil と MVR 術後2年全死亡との用量反応関係を明らかにし、右心系鬱血との関連性を検討すること。 動物 単一施設で MVR を受けた MMVD の犬、コホートA 2,063 頭およびコホートB 301 頭。 材料と方法 本後ろ向きコホート研究では、コホートA において Tbil と術後 2 年全死亡との関連を多変量 Cox 回帰モデルにより評価した。コホート B では、 Tbil と肝うっ血および右心負荷の関連を評価した。 結果 コホートA において、術前 Tbil は基準範囲内であっても2年全死亡と正の線形関連を示した (調整ハザード比 [0.3 対 0.1 mg/dL]: 1.33、95%信頼区間 1.04–1.70)。この関連は術後 30日を超えて生存した犬では消失した。さらに、術前 Tbil 高値は、コホートA における術後 30 日の心臓関連死亡頻度の増加、およびコホートB における退院時の右心負荷頻度の増加と関連し、この右心負荷は術後 1 か月までに消失した。肝うっ血所見は右心負荷所見と関連したが、 Tbil とは関連しなかった。 結論と臨床的意義 術前のわずかな Tbil 上昇は、術後短期全死亡および一過性の右心負荷と関連しており、基準範囲内の上昇であっても臨床的に重要な意味を持つ可能性がある。ただし、 Tbil と術後予後を結びつける病態生理学的機序は依然として明らかではない。